GSK reports 2% rise at Consumer Healthcare

14 February 2018 - Deborah Wilkes

Archived

Worldwide sales at GlaxoSmithKline Consumer Healthcare increased by 2% at constant exchange rates to GBP7.75 billion (USD10.8 billion) in 2017. The company said its performance had been “impacted by slower global growth in key categories”.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: